Cargando…
DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo
BACKGROUND: Malar melasma has a chronic and recurrent character that may be related to epigenetic changes. OBJECTIVE: To recognize the expression and DNA methylation of DNA methyltransferases (DNMTs) in malar melasma and perilesional skin, as well as the changes in DNMTs after their treatment with s...
Autores principales: | Campuzano-García, Andres Eduardo, Torres-Alvarez, Bertha, Hernández-Blanco, Diana, Fuentes-Ahumada, Cornelia, Cortés-García, Juan Diego, Castanedo-Cázares, Juan Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501269/ https://www.ncbi.nlm.nih.gov/pubmed/31143777 http://dx.doi.org/10.1155/2019/9068314 |
Ejemplares similares
-
Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study
por: Castanedo-Cazares, Juan Pablo, et al.
Publicado: (2013) -
A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma
por: Navarrete-Solís, Josefina, et al.
Publicado: (2011) -
The Role of Sunscreen in Melasma and Postinflammatory Hyperpigmentation
por: Fatima, Sakeena, et al.
Publicado: (2020) -
Leukemia cutis in a patient with pre–B-cell acute lymphoblastic leukemia
por: Campuzano-García, Andrés Eduardo, et al.
Publicado: (2015) -
Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)